FFT Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,510
Closed -$349K 163
2024
Q4
$349K Sell
3,510
-19
-0.5% -$1.96K 0.03% 124
2024
Q3
$401K Buy
3,529
+662
+23% +$78.6K 0.03% 105
2024
Q2
$355K Sell
2,867
-237
-8% -$30.5K 0.03% 105
2024
Q1
$410K Buy
3,104
+322
+12% +$39.7K 0.04% 87
2023
Q4
$303K Buy
2,782
+380
+16% +$39.4K 0.03% 88
2023
Q3
$247K Hold
2,402
0.03% 81
2023
Q2
$277K Sell
2,402
-33
-1% -$3.75K 0.03% 77
2023
Q1
$259K Buy
2,435
+40
+2% +$4.32K 0.03% 82
2022
Q4
$266K Buy
+2,395
New +$245K 0.03% 74
2021
Q4
Sell
-3,206
Closed -$241K 87
2021
Q3
$241K Buy
3,206
+36
+1% +$2.74K 0.02% 78
2021
Q2
$247K Buy
+3,170
New +$236K 0.06% 52

Other funds holding MRK

FFT Wealth Management's MRK Position: Q1 2025 in Review

FFT Wealth Management sold out of Merck (MRK) in Q1 2025, closing a stake of 3,510 shares — an estimated $349K sold.

FFT Wealth Management first reported a position in MRK in Q2 2021 and held it in 11 quarters. The position peaked at $410K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • FFT Wealth Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • FFT Wealth Management sold 3,510 Merck shares in Q1 2025, an estimated $349K.
  • FFT Wealth Management first reported a position in Merck in Q2 2021 and held it in 11 quarters.
  • FFT Wealth Management's Merck position peaked at $410K in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on FFT Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.